Combining qSOFA 1 with suPAR can help identify patients who will benefit from early treatment to prevent progression to severe sepsis.By ViroGates on Thu Feb 08 2024
suPAR is proven to be a significant marker in predicting 30-day and 90-day mortality in ED patientsBy ViroGates on Thu Jan 25 2024
Higher suPAR levels were associated with malaria severity and mortality among ugandan childrenBy ViroGates on Fri Dec 29 2023
Clinical role of suPAR in the prognosis of patients in the emergency setting and its influence on risk stratificationBy ViroGates on Wed Dec 06 2023
suPAR measurement in sepsis patients is about to change the early diagnosis processBy ViroGates on Mon Oct 02 2023
Increased inflammation measured by suPAR is associated with treatment responseBy ViroGates on Fri Sep 22 2023